BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for March 7-13, 2023

March 14, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Astellas, Astrazeneca, Ausperbio, Bionomics, Biothera Solutions, Daiichi Sankyo, Dyadic, Genfleet, Harbour, Immunovant, Innocare, JW.
Read More

Regulatory actions for March 14, 2023

March 14, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cathera, Visby Medical.
Read More

Other news to note for March 14, 2023

March 14, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Carthera, Concertai, Avicenna.AI, Elekta, Heartbeam, Leica Biosystems, Livmor, Masimo, Noze, Occlutech, Paige, Sophia Genetics, Sinopharm, Synaptive, Techcyte.
Read More

In the clinic for March 14, 2023

March 14, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acarix, Dariohealth, Photocure, Spire.
Read More

Appointments and advancements for March 14, 2023

March 14, 2023
New hires and promotions in the med-tech industry, including: CN Bio, Mindera Health, Tactile Systems Technology, Think Surgical, Visibly.
Read More

Regulatory actions for March 14, 2023

March 14, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Mersana.
Read More

Other news to note for March 14, 2023

March 14, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cingulate, Horizon, Indegene, Nuvo, Olatec, Oryzon, Searchlight.
Read More

In the clinic for March 14, 2023

March 14, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Alzecure, Aridis, Asahi, Biothera, Biovie, Boan, Calliditas, Gensight, Isotope, Luye, Pliant, Vectivbio.
Read More

Financings for March 14, 2023

March 14, 2023
Biopharmas raising money in public or private financings, including: Adamis, Algotx, Betterlife, Okyo, Switch.
Read More

Appointments and advancements for March 14, 2023

March 14, 2023
New hires and promotions in the biopharma industry, including: Biogen, Bryn, Clearmind, Crispr, DEM, Leo.
Read More
Previous 1 2 … 833 834 835 836 837 838 839 840 841 … 1792 1793 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing